Literature DB >> 1325580

Criteria for the definition of Epstein-Barr virus association in Hodgkin's disease.

A A Armstrong1, L M Weiss, A Gallagher, D B Jones, A S Krajewski, B Angus, G Brown, A S Jack, B S Wilkins, D E Onions.   

Abstract

There is a clear association between the Epstein-Barr virus (EBV) and Hodgkin's disease (HD). EBV is not, however, detectable within the affected tissues of all cases. The proportion of positive cases varies from 15-79% depending on the assay used to detect EBV. The techniques utilised vary not only in sensitivity but in their ability to detect viral DNA, RNA, or protein and in their ability to demonstrate the cellular localisation of the virus. Thus, the biological significance of a positive result will vary depending on the method of analysis. In the present study, four different methods of detecting EBV were compared. RNA in situ hybridization was found to be the most practical method of detecting EBV in tumour cells. Using this assay EBV was detected in the Reed-Sternberg cells of 33% and 45% of the two series of HD cases examined in this study. We believe that these cases should be considered EBV-associated.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1325580

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  10 in total

1.  A phase 1/2 trial of arginine butyrate and ganciclovir in patients with Epstein-Barr virus-associated lymphoid malignancies.

Authors:  Susan P Perrine; Olivier Hermine; Trudy Small; Felipe Suarez; Richard O'Reilly; Farid Boulad; Joyce Fingeroth; Melissa Askin; Arthur Levy; Steven J Mentzer; Massimo Di Nicola; Alessandro M Gianni; Christoph Klein; Steven Horwitz; Douglas V Faller
Journal:  Blood       Date:  2006-11-21       Impact factor: 22.113

2.  Expression of epstein-barr virus nuclear antigen 1 is associated with enhanced expression of CD25 in the Hodgkin cell line L428.

Authors:  D Kube; M Vockerodt; O Weber; K Hell; J Wolf; B Haier; F A Grässer; N Müller-Lantzsch; E Kieff; V Diehl; H Tesch
Journal:  J Virol       Date:  1999-02       Impact factor: 5.103

3.  No significant association of Epstein-Barr virus infection with invasive breast carcinoma.

Authors:  P G Chu; K L Chang; Y Y Chen; W G Chen; L M Weiss
Journal:  Am J Pathol       Date:  2001-08       Impact factor: 4.307

4.  Role of oncogenic viruses in the development ocular surface squamous neoplasia.

Authors:  Daniel Briscoe; Judit Krausz; Shirin Hamed-Azzam; Natalia Edison; Shahar Frenkel; Abed Mukari; Meirav Strauss; Hector Camacho; Irit Elmalah
Journal:  Int Ophthalmol       Date:  2021-06-25       Impact factor: 2.031

5.  Epstein-Barr virus patterns in US Burkitt lymphoma tumors from the SEER residual tissue repository during 1979-2009.

Authors:  Sam M Mbulaiteye; Sheeja T Pullarkat; Bharat N Nathwani; Lawrence M Weiss; Nagesh Rao; Benjamin Emmanuel; Charles F Lynch; Brenda Hernandez; Vishala Neppalli; Debra Hawes; Myles G Cockburn; Andre Kim; Makeda Williams; Sean Altekruse; Kishor Bhatia; Marc T Goodman; Wendy Cozen
Journal:  APMIS       Date:  2013-04-23       Impact factor: 3.205

6.  Association of Epstein-Barr virus with pediatric Hodgkin's disease.

Authors:  A A Armstrong; F E Alexander; R P Paes; N A Morad; A Gallagher; A S Krajewski; D B Jones; B Angus; J Adams; R A Cartwright
Journal:  Am J Pathol       Date:  1993-06       Impact factor: 4.307

7.  11. Cancers attributable to infection in the UK in 2010.

Authors:  D M Parkin
Journal:  Br J Cancer       Date:  2011-12-06       Impact factor: 7.640

8.  Lack of involvement of known oncogenic DNA viruses in Epstein-Barr virus-negative Hodgkin's disease.

Authors:  A A Armstrong; L Shield; A Gallagher; R F Jarrett
Journal:  Br J Cancer       Date:  1998-04       Impact factor: 7.640

9.  Risk factors for Hodgkin's disease by Epstein-Barr virus (EBV) status: prior infection by EBV and other agents.

Authors:  F E Alexander; R F Jarrett; D Lawrence; A A Armstrong; J Freeland; D A Gokhale; E Kane; G M Taylor; D H Wright; R A Cartwright
Journal:  Br J Cancer       Date:  2000-03       Impact factor: 7.640

10.  Prevalence of Common Non-Hodgkin Lymphomas and Subtypes of Hodgkin Lymphoma by Nodal Site of Involvement: A Systematic Retrospective Review of 938 Cases.

Authors:  Camille Laurent; Catherine Do; Pierre-Antoine Gourraud; Geisilene Russano de Paiva; Séverine Valmary; Pierre Brousset
Journal:  Medicine (Baltimore)       Date:  2015-06       Impact factor: 1.889

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.